Lexeo Therapeutics Q1 2026 Earnings EPS Beat on Lower Operating Costs ELTX Q1 2026 Earnings EPS Miss as ClinicalStage Biotech Advances Pipeline Without Revenue SLE Q1 2026 Earnings EPS Beat Overshadowed by Revenue Concerns and Stock Slide GM Q1 2026 Earnings Earnings Per Share Smashes Estimates Driving Optimism MAIN Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Declines